JCR Pharmaceuticals Co (TSE:4552) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4552 JCR Pharmaceuticals Co Ltd TSE:4552
42 GF Score
Price 円522.00
GF Value 円770.84
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is JCR Pharmaceuticals Co Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

JCR Pharmaceuticals Co Valuation Rank Related Terms

TSE:4552
42GF Score
JCR Pharmaceuticals Co Ltd TSE:4552
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is JCR Pharmaceuticals Co (TSE:4552) Overvalued in 2026?

Based on GuruFocus' analysis, JCR Pharmaceuticals Co stock appears to be undervalued. The current stock price of 円522.00 is trading 32.3% below its estimated GF Value™ of 円770.84. GuruFocus considers JCR Pharmaceuticals Co to be Possible Value Trap.

Key valuation signals for TSE:4552:

  • Valuation Rank:
  • GF Value™: 円770.84 vs. price of 円522.00 (32.3% below fair value)
  • GF Score™: 42/100 with 7 warning signs

No single metric tells the full story. See the TSE:4552 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

JCR Pharmaceuticals Co Business Description

Other Exchanges JCRRF:USA
Address 3-19 Kasuga-cho, Ashiya, Hyogo, JPN, 659-0021
JCR Pharmaceuticals Co Ltd is a major drug manufacturing company proactively engaged in the research of enzymes and proteins. The company maintains a focus toward developing value-added treatment options to address unmet medical needs. JCR utilizes international partnerships as a component of its growth strategy. The vast majority of JCR's revenue is generated from its pharmaceutical operations, followed by medical devices and laboratory equipment. A portion of the company's sales are derived from licensing agreements.
42GF Score

Get the complete analysis for TSE:4552

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円522.00
Price
円770.84
GF Value